Answers are grounded in this paper and cite their sources.
Botulinum neurotoxin (BoNT) is renowned for its inhibitory effects on the neuromuscular junction. The evidence for its use in cosmetic dermatology and in non-dermatological indications is well established. We have systemically analysed the evidence for the non-cosmetic dermatological uses of BoNT. This review presents the many small studies showing promising results for the use of BoNT in a multitude of dermatological diseases, including (but not limited to) hyperhidrosis, Darier's disease, Hailey-Hailey disease, pompholyx and hidradenitis suppurativa. There is, however, the need for larger, double-blinded randomized control trials against established treatments to cement the evidence base underlying the use of BoNT in dermatology.
No takes yet. Share an insight, caveat, or question.
Forbat et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: